Astra Industrial Group Company (1212.SR)
SAR 186.8
(3.2%)
SAR 186.8
(3.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 681 Million | 357.18 Million | 378.47 Million | 272.03 Million | 374.29 Million | 76.94 Million |
| Net Income | 502.07 Million | 519.86 Million | 219.67 Million | 144.05 Million | 12.44 Million | 34.49 Million |
| Depreciation & Amortization | 90.42 Million | 78.94 Million | 93.97 Million | 89.68 Million | 82.41 Million | 71.57 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -20.35 Million | -137.02 Million | -23.47 Million | -101.11 Million | 83.18 Million | -193.9 Million |
| Other non-cash items | 108.85 Million | -104.59 Million | 88.3 Million | 139.4 Million | 196.25 Million | 164.78 Million |
| Investing Cash Flow | -88.08 Million | 571.97 Million | -80.45 Million | -56.24 Million | -63.24 Million | -53.91 Million |
| Investments in PPE | -88.08 Million | -64.56 Million | -80.45 Million | -66.22 Million | -39.94 Million | -57.33 Million |
| Acquisitions | -2630.00 | 636.53 Million | - | - | -19.81 Million | -5.57 Million |
| Investment purchases | - | - | - | - | -20.53 Million | -5.57 Million |
| Sales/Maturities of investments | - | - | - | - | 20.53 Million | - |
| Other Investing Activities | 2630.00 | 658.33 Million | -6.04 Million | 9.97 Million | -3.48 Million | 8.99 Million |
| Financing Cash Flow | -228.45 Million | -364.03 Million | -308.02 Million | -212.24 Million | -334.23 Million | -3.53 Million |
| Debt repayment | -5.11 Million | -4.23 Million | -2.01 Million | -108.87 Million | -7.1 Million | -106.8 Million |
| Dividends payments | -200 Million | -120 Million | -60 Million | - | - | -40 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23.34 Million | -239.79 Million | -246 Million | -103.36 Million | -327.12 Million | 36.46 Million |
| Accounts receivables | -119.62 Million | -106.19 Million | -32.72 Million | -45.8 Million | 123.31 Million | -93.79 Million |
| Accounts payables | -2.99 Million | 44.29 Million | -14.15 Million | 77.81 Million | -19.01 Million | -65.13 Million |
| Inventory | 21.82 Million | -161.89 Million | -41.46 Million | -207.16 Million | -21.37 Million | -49.52 Million |
| Other working capital | 80.43 Million | 86.76 Million | 64.87 Million | 74.03 Million | 260.58 Thousand | -144.38 Million |
| Cash at beginning of period | 675.74 Million | 46.31 Million | 54.46 Million | 45.27 Million | 65.46 Million | 76.64 Million |
| Cash at end of period | 1.05 Billion | 675.74 Million | 46.31 Million | 54.46 Million | 45.27 Million | 65.46 Million |
| Capital Expenditure | -88.08 Million | -64.56 Million | -80.45 Million | -66.22 Million | -39.94 Million | -57.33 Million |
| Effect of forex changes on cash | 17.89 Million | 64.3 Million | 1.85 Million | 5.63 Million | 2.99 Million | -22.72 Million |
| Net cash flow / Change in cash | 382.35 Million | 629.43 Million | -8.14 Million | 9.18 Million | -20.18 Million | -11.17 Million |
| Free Cash Flow | 592.91 Million | 292.61 Million | 298.01 Million | 205.8 Million | 334.35 Million | 19.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 117.72 Million | 149.74 Million | 133.94 Million | 502.07 Million | 111.77 Million | 121.48 Million |
| Depreciation & Amortization | 18.66 Million | 18.99 Million | 29.33 Million | 90.42 Million | 20.3 Million | 20.4 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -170.7 Million | -108.26 Million | 111.85 Million | -20.35 Million | 71.81 Million | -48.19 Million |
| Other non-cash items | 161.97 Million | 213.84 Million | 34.14 Million | 108.85 Million | 41.66 Million | 3.91 Million |
| Investing Cash Flow | -825.1 Million | -174.33 Million | -37.95 Million | -88.08 Million | -21.46 Million | -18.47 Million |
| Investments in PPE | -20.14 Million | -176.74 Million | -37.02 Million | -88.08 Million | -21.55 Million | -18.74 Million |
| Acquisitions | 34.92 Million | - | -2630.00 | -2630.00 | - | - |
| Investment purchases | -837.48 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.4 Million | 2.4 Million | -924.78 Thousand | 2630.00 | 91.63 Thousand | 263.72 Thousand |
| Financing Cash Flow | 646.9 Million | -634.58 Million | -283.47 Million | -228.45 Million | 88.21 Million | -50.93 Million |
| Debt repayment | -308.47 Million | -221.34 Million | -141.15 Million | -5.11 Million | -111.64 Million | -170.83 Million |
| Dividends payments | -200 Million | - | - | -200 Million | - | -200 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 540.77 Million | -411.22 Million | -283.47 Million | -23.34 Million | 199.85 Million | 319.9 Million |
| Accounts receivables | -53.14 Million | -235.59 Million | 106.37 Million | -119.62 Million | 72.13 Million | -44.96 Million |
| Accounts payables | 14.97 Million | 38.81 Million | -12.23 Million | -2.99 Million | -2.1 Million | -6.06 Million |
| Inventory | -58.62 Million | 53.97 Million | 23.51 Million | 21.82 Million | -33.26 Million | 23.75 Million |
| Other working capital | -73.91 Million | 34.54 Million | -5.81 Million | 80.43 Million | 35.04 Million | -20.91 Million |
| Cash at beginning of period | 345.46 Million | 1.05 Billion | 1.06 Billion | 675.74 Million | 744.65 Million | 714.31 Million |
| Cash at end of period | 170.54 Million | 345.46 Million | 1.05 Billion | 1.05 Billion | 1.06 Billion | 744.65 Million |
| Capital Expenditure | -20.14 Million | -176.74 Million | -37.02 Million | -88.08 Million | -21.55 Million | -18.74 Million |
| Effect of forex changes on cash | 9.04 Million | 3.32 Million | 6.51 Million | 17.89 Million | 6.78 Million | 2.13 Million |
| Net cash flow / Change in cash | -174.92 Million | -712.77 Million | -5.64 Million | 382.35 Million | 319.08 Million | 30.34 Million |
| Free Cash Flow | -26.6 Million | -83.22 Million | 272.24 Million | 592.91 Million | 223.99 Million | 78.87 Million |
ULTRACEMCO
002369
ODAS
TCTZF
INDOAMIN
SHRIRAMPPS